George W. Lloyd - 23 May 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP, Investments & GC
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Issuer symbol: RPRX
Transactions as of: 23 May 2022
Transactions value $: -$4,026,770
Form type: 4
Filing time: 25 May 2022, 17:10:27 UTC
Previous filing: 18 Nov 2021
Next filing: 31 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	-$4.03M	-100K	-15.87%	$40.27	530K	23 May 2022	By GWL 2014 G, LLC	F1
holding	RPRX	Class A Ordinary Shares						496K	23 May 2022	By GWL 2013 NG, LLC
holding	RPRX	Class A Ordinary Shares						240K	23 May 2022	By GWL 2020 G, LLC
holding	RPRX	Class A Ordinary Shares						3K	23 May 2022	Direct
holding	RPRX	Class A Ordinary Shares						274K	23 May 2022	By IRA
holding	RPRX	Class A Ordinary Shares						4.01K	23 May 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.